Filtered By:
Source: Journal of Korean Medical Science
Countries: South Korea Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 334 results found since Jan 2013.
Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients
CONCLUSION: Nirmatrelvir-ritonavir treatment significantly reduced oxygen therapy requirements in high-risk patients with COVID-19 during the omicron variant surge in South Korea. Physicians are encouraged to consider the active use of nirmatrelvir-ritonavir and to be watchful for gastrointestinal symptoms during medication.PMID:37667578 | PMC:PMC10477076 | DOI:10.3346/jkms.2023.38.e272
Source: Journal of Korean Medical Science - September 5, 2023 Category: Biomedical Science Authors: Min-Kyung Kim Kyung-Shin Lee Sin Young Ham Youn Young Choi Eunyoung Lee Seungjae Lee Bora Lee Jaehyun Jeon BumSik Chin Yeonjae Kim Gayeon Kim Hee-Chang Jang Jae-Phil Choi Sang-Won Park Source Type: research
Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
CONCLUSION: In these data, vaccination history was significantly related to reduced COVID-19 reinfection and severe progression, and scheduled vaccinations were important even with a history of infection.PMID:37644683 | DOI:10.3346/jkms.2023.38.e269
Source: Journal of Korean Medical Science - August 30, 2023 Category: Biomedical Science Authors: Ju Hee Lee Ji Hae Hwang Eun Jung Jang Ryu Kyung Kim Kil Hun Lee Seon Kyeong Park Jin Gwack Young Joon Park Source Type: research
A Model-Based Cost-Effectiveness Analysis of Long-Acting Monoclonal Antibody (Tixagevimab and Cilgavimab: Evusheld) Preventive Treatment for High-Risk Populations Against SARS-CoV-2 in Korea
CONCLUSION: As the COVID-19 variants and risk group-specific durable efficacy, toxicity (and/or resistance) and optimal dosing of Evusheld remain uncertain, better empirical estimates to inform these values in different epidemiological contexts are needed. These results may help decision-makers prioritize resources toward more equitable and effective COVID-19 control efforts.PMID:37582500 | DOI:10.3346/jkms.2023.38.e250
Source: Journal of Korean Medical Science - August 15, 2023 Category: Biomedical Science Authors: Youngji Jo Sun Bean Kim Jaehun Jung Source Type: research
